1. Large library docking identifies positive allosteric modulators of the calcium-sensing receptor.
- Author
-
Liu F, Wu CG, Tu CL, Glenn I, Meyerowitz J, Kaplan AL, Lyu J, Cheng Z, Tarkhanova OO, Moroz YS, Irwin JJ, Chang W, Shoichet BK, and Skiniotis G
- Subjects
- Animals, Humans, Mice, Allosteric Regulation, Cinacalcet pharmacokinetics, Cinacalcet pharmacology, Protein Conformation, Cryoelectron Microscopy, Molecular Docking Simulation, Parathyroid Hormone metabolism, Receptors, Calcium-Sensing agonists, Receptors, Calcium-Sensing antagonists & inhibitors, Receptors, Calcium-Sensing chemistry, Small Molecule Libraries chemistry, Small Molecule Libraries pharmacology, Drug Discovery, Calcimimetic Agents chemistry, Calcimimetic Agents pharmacokinetics, Calcimimetic Agents pharmacology
- Abstract
Positive allosteric modulator (PAM) drugs enhance the activation of the calcium-sensing receptor (CaSR) and suppress parathyroid hormone (PTH) secretion. Unfortunately, these hyperparathyroidism-treating drugs can induce hypocalcemia and arrhythmias. Seeking improved modulators, we docked libraries of 2.7 million and 1.2 billion molecules against the CaSR structure. The billion-molecule docking found PAMs with a 2.7-fold higher hit rate than the million-molecule library, with hits up to 37-fold more potent. Structure-based optimization led to nanomolar leads. In ex vivo organ assays, one of these PAMs was 100-fold more potent than the standard of care, cinacalcet, and reduced serum PTH levels in mice without the hypocalcemia typical of CaSR drugs. As determined from cryo-electron microscopy structures, the PAMs identified here promote CaSR conformations that more closely resemble the activated state than those induced by the established drugs.
- Published
- 2024
- Full Text
- View/download PDF